70710-1398-3 : NDC 2026 Code

70710-1398-3 : Eltrombopag ( Eltrombopag )

Additionally :

You can get information about “70710-1398-3” NDC code in 70710-1398-3 in HTML format

HTML | 70710-1398-3 in TXT (Plain Text) format

TXT | 70710-1398-3 in PDF (Portable Document Format)

PDF | 70710-1398-3 in XML format

XML formats.

NDC Code : 70710-1398-3 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "70710-1398-3",
    "PackageDescription": "30 TABLET in 1 BOTTLE (70710-1398-3) ",
    "NDC11Code": "70710-1398-03",
    "ProductNDC": "70710-1398",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Eltrombopag",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Eltrombopag",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260114",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA216281",
    "LabelerName": "Zydus Pharmaceuticals USA Inc.",
    "SubstanceName": "ELTROMBOPAG OLAMINE",
    "StrengthNumber": "75",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-01-23",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260114",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}